CLINICO-IMMUNOLOGICAL EVALUATION OF THE EFFECTIVENESS OF INTRAVENOUS IMMUNOGLOBULINS AS AN ADJUVANT THERAPY FOR SURGICAL SEPSIS
We observed 46 patients with sepsis, which were divided into 2 groups. I group (25 patients) received traditional treatment, II group (21 patients) in addition to conventional therapy received enriched IVIG (IgM+IgA). Comparative assessment of the combination of intravenous immunoglobulin’s and traditional therapy indicated the clinical effectiveness of IVIG therapy, which results in reducing the severity of systemic inflammation, the severity of the disease and the mortality in patients with surgical sepsis.